-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
L-Lysine-13C6,15N2 hydrochloride
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1200447-00-22d.gif)
| Category | Virus Protease |
| CAS | 1200447-00-2 |
| Description | L-Lysine-[13C6,15N2] Hydrochloride is the labelled analogue of L-Lysine hydrochloride, which has been used in SILAC isotopic labeling for the characterization of lysine racemase. |
Product Information
| Synonyms | L-Lysine-13C6,15N2 hydrochloride;L-Lysine-13C6,15N2 (hydrochloride);1200447-00-2;HY-N0470S3;CS-0379556;L-Lysine-13C6,15N2 hydrochloride, 99 atom % 13C, 99 atom % 15N, 95% (CP); |
| IUPAC Name | (2S)-2,6-bis(15N)(azanyl)(1,2,3,4,5,6-13C6)hexanoic acid;hydrochloride |
| Molecular Weight | 190.59 |
| Molecular Formula | 13C6H15Cl15N2O2 |
| Canonical SMILES | O=[13C](O)[13C@H]([13CH2][13CH2][13CH2][13CH2][15NH2])[15NH2].Cl |
| InChI | InChI=1S/C6H14N2O2.ClH/c7-4-2-1-3-5(8)6(9)10;/h5H,1-4,7-8H2,(H,9,10);1H/t5-;/m0./s1/i1+1,2+1,3+1,4+1,5+1,6+1,7+1,8+1; |
| InChIKey | BVHLGVCQOALMSV-GSMNGUNQSA-N |
| Melting Point | 263-264°C (dec.) (lit.) |
| Purity | 95% by HPLC; 99% atom 15N, 99% atom 13C |
| Solubility | Slightly soluble in Aqueous Acid, Water |
| Appearance | Solid |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
